Global Famotidine Injection
Market Report
2025
Delivery Includes:- Market Timeline 2021 till 2033, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Famotidine Injection Market Report 2025.
"Global Famotidine Injection market size 2025 is $650.2 Million whereas according out published study it will reach to $1052.07 Million by 2033. Famotidine Injection market will be growing at a CAGR of 6.2% during 2025 to 2033."
As per the current market study, out of 650.2 Million USD global market revenue 2025, North America market holds 30.50% of the market share. The North America Famotidine Injection industry grew from 157.434 Million USD in 2021 to 198.311 Million USD in 2025 and will record 79.39% growth. In coming future this industry will reach 316.672 Million by 2033 with a 6.025% CAGR. If we look at the percentage market shares of top North America countries for 2025,Mexico (4.10%), Canada (11.60%), United States (84.30%)
As per the current market study, out of 650.2 Million USD global market revenue 2025, Europe market holds 27.80% of the market share. The Europe Famotidine Injection industry grew from 143.633 Million USD in 2021 to 180.756 Million USD in 2025 and will record 79.46% growth. In coming future this industry will reach 284.058 Million by 2033 with a 5.813% CAGR. If we look at the percentage market shares of top Europe countries for 2025,Denmark (2.50%), France (10.30%), Sweden (3.30%), Germany (23.50%), Spain (7.60%), United Kingdom (15.00%), Luxembourg (1.60%), Russia (11.80%), Switzerland (2.80%), Italy (8.00%), Rest of Europe (13.60%)
As per the current market study, out of 650.2 Million USD global market revenue 2025, Asia Pacific market holds 31.60% of the market share. The Asia Pacific Famotidine Injection industry grew from 159.479 Million USD in 2021 to 205.463 Million USD in 2025 and will record 77.62% growth. In coming future this industry will reach 346.13 Million by 2033 with a 6.737% CAGR. If we look at the percentage market shares of top Asia Pacific countries for 2025,South Korea (5.50%), India (17.80%), South East Asia (8.60%), Japan (12.10%), Singapore (1.40%), China (40.10%), Australia (3.20%), Rest of APAC (11.30%)
2024 | 2025 | 2032 | 2033 | CAGR | |
---|---|---|---|---|---|
Global Famotidine Injection Market Sales Revenue | 121212 | $ 650.2 Million | 121212 | $ 1052.07 Million | 6.2% |
North America Famotidine Injection Market Sales Revenue | 121212 | $ 198.311 Million | 121212 | $ 316.672 Million | 6.025% |
Mexico Famotidine Injection Market Sales Revenue | 121212 | $ 8.131 Million | 121212 | $ 14.567 Million | 7.561% |
Canada Famotidine Injection Market Sales Revenue | 121212 | $ 23.004 Million | 121212 | $ 36.417 Million | 5.91% |
United States Famotidine Injection Market Sales Revenue | 121212 | $ 167.176 Million | 121212 | $ 265.688 Million | 5.962% |
Europe Famotidine Injection Market Sales Revenue | 121212 | $ 180.756 Million | 121212 | $ 284.058 Million | 5.813% |
Denmark Famotidine Injection Market Sales Revenue | 121212 | $ 4.519 Million | 121212 | $ 6.817 Million | 5.275% |
France Famotidine Injection Market Sales Revenue | 121212 | $ 18.618 Million | 121212 | $ 28.974 Million | 5.684% |
Sweden Famotidine Injection Market Sales Revenue | 121212 | $ 5.965 Million | 121212 | $ 8.522 Million | 4.56% |
Germany Famotidine Injection Market Sales Revenue | 121212 | $ 42.478 Million | 121212 | $ 65.901 Million | 5.643% |
Spain Famotidine Injection Market Sales Revenue | 121212 | $ 13.737 Million | 121212 | $ 20.736 Million | 5.282% |
United Kingdom Famotidine Injection Market Sales Revenue | 121212 | $ 27.113 Million | 121212 | $ 41.472 Million | 5.456% |
Luxembourg Famotidine Injection Market Sales Revenue | 121212 | $ 2.892 Million | 121212 | $ 3.693 Million | 3.102% |
Russia Famotidine Injection Market Sales Revenue | 121212 | $ 21.329 Million | 121212 | $ 32.951 Million | 5.587% |
Switzerland Famotidine Injection Market Sales Revenue | 121212 | $ 5.061 Million | 121212 | $ 7.386 Million | 4.837% |
Italy Famotidine Injection Market Sales Revenue | 121212 | $ 14.46 Million | 121212 | $ 22.157 Million | 5.479% |
Rest of Europe Famotidine Injection Market Sales Revenue | 121212 | $ 24.583 Million | 121212 | $ 45.449 Million | 7.985% |
Asia Pacific Famotidine Injection Market Sales Revenue | 121212 | $ 205.463 Million | 121212 | $ 346.13 Million | 6.737% |
South Korea Famotidine Injection Market Sales Revenue | 121212 | $ 11.3 Million | 121212 | $ 18.691 Million | 6.492% |
India Famotidine Injection Market Sales Revenue | 121212 | $ 36.572 Million | 121212 | $ 62.649 Million | 6.96% |
South East Asia Famotidine Injection Market Sales Revenue | 121212 | $ 17.67 Million | 121212 | $ 29.075 Million | 6.423% |
Japan Famotidine Injection Market Sales Revenue | 121212 | $ 24.861 Million | 121212 | $ 40.843 Million | 6.402% |
Singapore Famotidine Injection Market Sales Revenue | 121212 | $ 2.876 Million | 121212 | $ 4.154 Million | 4.7% |
China Famotidine Injection Market Sales Revenue | 121212 | $ 82.391 Million | 121212 | $ 140.183 Million | 6.869% |
Australia Famotidine Injection Market Sales Revenue | 121212 | $ 6.575 Million | 121212 | $ 10.038 Million | 5.431% |
Rest of APAC Famotidine Injection Market Sales Revenue | 121212 | $ 23.217 Million | 121212 | $ 40.497 Million | 7.202% |
South America Famotidine Injection Market Sales Revenue | 121212 | $ 21.468 Million | 121212 | $ 25.358 Million | 38.926% |
Brazil Famotidine Injection Market Sales Revenue | 121212 | $ 11.563 Million | 121212 | $ 17.809 Million | 5.547% |
Chile Famotidine Injection Market Sales Revenue | 121212 | $ 1.598 Million | 121212 | $ 2.336 Million | 4.862% |
Peru Famotidine Injection Market Sales Revenue | 121212 | $ 1.775 Million | 121212 | $ 2.686 Million | 5.314% |
Colombia Famotidine Injection Market Sales Revenue | 121212 | $ 2.105 Million | 121212 | $ 3.192 Million | 5.344% |
Argentina Famotidine Injection Market Sales Revenue | 121212 | $ 3.854 Million | 121212 | $ 5.8 Million | 5.241% |
Rest of South America Famotidine Injection Market Sales Revenue | 121212 | $ 4.463 Million | 121212 | $ 7.104 Million | 5.983% |
Middle East Famotidine Injection Market Sales Revenue | 121212 | $ 18.401 Million | 121212 | $ 26.008 Million | 44.187% |
UAE Famotidine Injection Market Sales Revenue | 121212 | $ 4.681 Million | 121212 | $ 8.086 Million | 7.071% |
Turkey Famotidine Injection Market Sales Revenue | 121212 | $ 5.618 Million | 121212 | $ 9.412 Million | 6.663% |
Saudi Arabia Famotidine Injection Market Sales Revenue | 121212 | $ 5.072 Million | 121212 | $ 8.749 Million | 7.054% |
Qatar Famotidine Injection Market Sales Revenue | 121212 | $ 2.081 Million | 121212 | $ 3.402 Million | 6.34% |
Egypt Famotidine Injection Market Sales Revenue | 121212 | $ 3.173 Million | 121212 | $ 5.258 Million | 6.518% |
Rest of Middle East Famotidine Injection Market Sales Revenue | 121212 | $ 5.384 Million | 121212 | $ 9.279 Million | 7.042% |
Africa Famotidine Injection Market Sales Revenue | 121212 | $ 10.734 Million | 121212 | $ 14.304 Million | 22.093% |
South Africa Famotidine Injection Market Sales Revenue | 121212 | $ 6.694 Million | 121212 | $ 10.296 Million | 5.528% |
Nigeria Famotidine Injection Market Sales Revenue | 121212 | $ 2.918 Million | 121212 | $ 4.595 Million | 5.841% |
Rest of Africa Famotidine Injection Market Sales Revenue | 121212 | $ 8.531 Million | 121212 | $ 14.405 Million | 6.768% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Type |
|
Market Split by Application |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
|
Report scope is customizable as we have a huge database of Famotidine Injection industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Famotidine Injection Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Growing Prevalence of Gastrointestinal Disorders: As a result of the rising prevalence of conditions such peptic ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease (GERD), there is a greater need for famotidine injections. ?
Technological Developments in Drug Delivery: Advances in the administration of famotidine, including pre-filled syringes and sophisticated multi-dose vials, have improved patient compliance and increased the medication's use in a variety of healthcare settings.
Expanding Healthcare Infrastructure in Emerging Economies: As a result of investments made in healthcare infrastructure, nations such as China and India are seeing a rise in the use of famotidine injections.
Advanced Market Analysis
Preference for Non-Invasive Treatments: Patients who are unable to take oral drugs may find that famotidine injections provide a good substitute. Non-invasive therapy options are becoming more and more popular. ?
Proton Pump Inhibitors' (PPIs') Competition: Because PPIs are so good at lowering the production of stomach acid, they are frequently chosen over H2 receptor blockers like Famotidine, which makes it difficult for the market to expand.
Possible Adverse Reactions: Famotidine is usually well tolerated, although some patient populations may not be able to utilize it because of adverse effects such agranulocytosis.
Regulatory Obstacles: Tight regulations pertaining to drug approval and marketing may restrict the release of novel formulations, which could hinder market growth.
Creation of Advanced Formulations: To improve treatment results, research is being done to create safer and more effective forms of famotidine, such as combination therapies and extended-release forms. ?
Growth of Online Pharmacies: The emergence of online pharmacies is facilitating the availability of Famotidine injections, particularly in rural regions, which is fueling the market's expansion. ?
Preventive healthcare is becoming more and more important:which will increase the demand for famotidine injections by enabling the early detection and treatment of gastrointestinal diseases.
We have various report editions of Famotidine Injection Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.
The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.
Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.
Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.
Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.
The pharmaceutical and healthcare industry is highly competitive, with key players expanding their portfolios through new product launches, mergers and acquisitions, strategic partnerships, and regulatory approvals.
Financial performance metrics include revenue, gross margin, and market share, as well as SWOT analysis for key players. The report also evaluates companies' responses to COVID-19 challenges, including supply chain adjustments and investments in digital healthcare solutions.
The market size is projected based on global, regional, and country-level demand patterns, with research including value chain analysis, patent analysis, and competitive matrix. This comprehensive study serves as a vital resource for investors, industry stakeholders, and businesses navigating the evolving pharmaceutical and healthcare landscape.
Top Companies Market Share in Famotidine Injection Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Region and country analysis section of Famotidine Injection Industry Analysis has been segmented into 5 major region such as North America, Europe, Asia Pacific, Middle East & Africa ,and Latin America (along with respective major contributing countries) and provides the revenue share, current trends.
The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of Famotidine Injection market.
The current report Scope analyzes Famotidine Injection Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Global Famotidine Injection Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Famotidine Injection Industry growth. Famotidine Injection market has been segmented with the help of its Type, Application , and others. Famotidine Injection market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
This report categorizes competitors in the pharmaceutical and healthcare market based on their product offerings and business models. It includes key details such as definitions, benefits, applications, technological advancements, and regional advantages for each type of pharmaceutical product, including small molecule drugs, biologics, and biosimilars.
Market growth figures, such as market share percentages, revenue, and growth rates (e.g., CAGR), are provided for each segment over the specified period (2019-2023). The report covers various segments
Type of Famotidine Injection analyzed in this report are as follows:
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Famotidine Injection Industry. Request a Free Sample PDF!
This report analyzes revenue growth in the pharma and healthcare industry at global, regional, and national levels, highlighting trends and opportunities for each application. It explores how sectors like pharmaceuticals, therapy, and healthcare monitoring use innovations to address healthcare needs. Key factors include market size, revenue contributions, technological advancements (e.g., AI-driven diagnostics), and regulatory considerations. The report also covers the value chain, identifying key players and processes within the industry. For more information, please request a sample or contact our research team.
Some of the key Application of Famotidine Injection are:
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Senior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Famotidine Injection Market is witnessing significant growth in the near future.
In 2023, the Type I segment accounted for noticeable share of global Famotidine Injection Market and is projected to experience significant growth in the near future.
The Application 1 segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Medline Industries, Ciron Pharma and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Type | Type I, Type II |
Application | Application 1, Application 2 |
List of Competitors | Medline Industries, Mylan, Ciron Pharma, McKesson Pharma, CVS Health, Allegiance Health |
This chapter will help you gain GLOBAL Market Analysis of Famotidine Injection. Further deep in this chapter, you will be able to review Global Famotidine Injection Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Famotidine Injection. Further deep in this chapter, you will be able to review North America Famotidine Injection Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Famotidine Injection. Further deep in this chapter, you will be able to review Europe Famotidine Injection Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Famotidine Injection. Further deep in this chapter, you will be able to review Asia Pacific Famotidine Injection Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Famotidine Injection. Further deep in this chapter, you will be able to review South America Famotidine Injection Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Famotidine Injection. Further deep in this chapter, you will be able to review Middle East Famotidine Injection Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Famotidine Injection. Further deep in this chapter, you will be able to review Middle East Famotidine Injection Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Famotidine Injection. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Famotidine Injection market
Chapter 12 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 13 Research Methodology and Sources
Why Type I have a significant impact on Famotidine Injection market? |
What are the key factors affecting the Type I and Type II of Famotidine Injection Market? |
What is the CAGR/Growth Rate of Application 1 during the forecast period? |
By type, which segment accounted for largest share of the global Famotidine Injection Market? |
Which region is expected to dominate the global Famotidine Injection Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|